Astrazeneca Pharma India Ltd.

₹9180.5

Astrazeneca Pharma India Ltd.

₹9180.5

₹9180.5

20.5 (0.22%) - 16 Jul 2025 01:23 PM

About Company

AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. The company is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. Rated as one of the finest in South East Asia, AstraZeneca’s Indian manufacturing facility has a sophisticated production facility designed to meet the most stringent international standards, conforming to WHO cGMP (current Good Manufacturing Practices) norms. The facility is an ISO 14001 certified company and has a full-fledged environment management system in place.

Market Cap. ₹ 22,900 Cr.
52 Week - High/Low ₹ 10,691/6,220
P/E Ratio 197.88
P/B Ratio 32.17
Enterprise Value ₹ 22,409 Cr.
ROE % 24.95
RSI Value 38.24
EMA 50 8934.14
EMA 200 7886.63
Market Cap. ₹ 22,900 Cr.
52 Week - High/Low ₹ 10,691/6,220
P/E Ratio N/A
P/B Ratio N/A
Enterprise Value -
ROE % N/A
RSI Value 38.24
EMA 50 8934.14
EMA 200 7886.63

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.